Buscar
Standard BioTools Inc
LABAñadir a la lista de seguimiento
0.868USD
-0.029-3.27%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
339.79MCap. mercado
4.34P/E TTM
Más Datos de Standard BioTools Inc Compañía
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Información de Standard BioTools Inc
Símbolo de cotizaciónLAB
Nombre de la empresaStandard BioTools Inc
Fecha de salida a bolsaFeb 10, 2011
Director ejecutivoEgholm (Michael)
Número de empleados818
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 10
Dirección2 Tower Place
CiudadSOUTH SAN FRANCISCO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94080
Teléfono16502666000
Sitio Webhttps://www.standardbio.com/
Símbolo de cotizaciónLAB
Fecha de salida a bolsaFeb 10, 2011
Director ejecutivoEgholm (Michael)
Ejecutivos de Standard BioTools Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
317.28K
+61.05%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
317.28K
+61.05%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Standard BioTools Inc?
Los cinco principales accionistas de Standard BioTools Inc son: Mr. Sean Mackay
¿Cuántas instituciones poseen acciones de Standard BioTools Inc (LAB)?
A fecha de 2026Q1, 342 instituciones poseen acciones de Standard BioTools Inc, con un valor de mercado combinado de aproximadamente 317.36M, lo que representa el 81.30% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 773508.00.
¿Cuál es la mayor fuente de ganancias de Standard BioTools Inc?
El 2026Q1, el segmento empresarial Consumables generó la ganancia más alta para Standard BioTools Inc, ascendiendo a 36.25M y representando el 42.48% de la ganancia total.